Old Web
English
Sign In
Acemap
>
authorDetail
>
Rachel Busse‐Reid
Rachel Busse‐Reid
Hoffmann-La Roche
MEK inhibitor
Pharmacodynamics
Peripheral blood mononuclear cell
Disposition
Tolerability
2
Papers
46
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of RO5068760, an MEK Inhibitor, in Healthy Volunteers: Assessment of Target Suppression
2010
The Journal of Clinical Pharmacology
Lucy Lee
Huifeng Niu
Petra Goelzer
Ruediger Rueger
Jonathan Deutsch
Rachel Busse‐Reid
Stefanie DeSchepper
Steve Blotner
Joanne Barrett
Georges Weissgerber
Richard Peck
Show All
Source
Cite
Save
Citations (9)
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker
2009
Clinical Cancer Research
Lucy Lee
Huifeng Niu
Ruediger Rueger
Yuriko Igawa
Jonathan Deutsch
Nobuya Ishii
Song Mu
Yuuichiro Sakamoto
Rachel Busse‐Reid
Claude Gimmi
Petra Goelzer
Stefanie De Schepper
Yashushi Yoshimura
Joanne Barrett
Yuji Ishikawa
Georges Weissgerber
Richard Peck
Show All
Source
Cite
Save
Citations (37)
1